Literature DB >> 19301473

Factors determining the risk of inadvertent retroviral transduction of male germ cells after in utero gene transfer in sheep.

Paul J Park1, Evan Colletti, Ferhat Ozturk, Josh A Wood, Joe Tellez, Graça Almeida-Porada, Christopher Porada.   

Abstract

The possibility of permanent genetic changes to the germline is central to the bioethics of in utero gene therapy (IUGT) because of the concern of inadvertent potentially deleterious alterations to the gene pool. Despite presumed protection of the male germline due to early germ cell (GC) compartmentalization, we reported that GCs within the developing ovine testes are transduced at low levels after retrovirus-mediated IUGT, thus underscoring the need for a thorough understanding of GC development in clinically predictive models to determine the optimal time to perform IUGT and avoid germline modification. In the present studies, we used the fetal sheep model to analyze GCs for phenotype, location, proliferation, and incidence of transduction after IUGT at various fetal ages to learn when during development the nascent germline is likely to be at greatest risk of retrovirus-mediated alteration. Our studies show that although GCs were transduced at all injection ages, the levels of transduction varied by nearly 700-fold as a function of the age at transfer. After remaining largely quiescent as they migrated to/settled within nascent sex cords, GCs began active cycling before cord closure was complete, suggesting this is likely the point at which they would be most susceptible to retroviral transduction.Furthermore, we observed that compartmentalization of GCs continued into early postnatal life, suggesting the male germline may be vulnerable to low-level inadvertent retroviral vector modification throughout fetal life, but that this risk can be minimized by performing IUGT later in gestation.

Entities:  

Mesh:

Year:  2009        PMID: 19301473      PMCID: PMC2829302          DOI: 10.1089/hum.2007.120

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  68 in total

1.  In utero gene therapy: the case against.

Authors:  P R Billings
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

Review 2.  Primordial germ cell development in zebrafish.

Authors:  Erez Raz
Journal:  Semin Cell Dev Biol       Date:  2002-12       Impact factor: 7.727

Review 3.  The hopes and fears of in utero gene therapy for genetic disease--a review.

Authors:  C Coutelle; M Themis; S Waddington; L Gregory; M Nivsarkar; S Buckley; T Cook; C Rodeck; D Peebles; A David
Journal:  Placenta       Date:  2003-10       Impact factor: 3.481

4.  Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer.

Authors:  Christopher D Porada; Paul J Park; Graça Almeida-Porada; Wansheng Liu; Ferhat Ozturk; Hudson A Glimp; Esmail D Zanjani
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

5.  Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1.

Authors:  Roberto Bilbao; Daniel P Reay; Juan Li; Xiao Xiao; Paula R Clemens
Journal:  Hum Gene Ther       Date:  2005-06       Impact factor: 5.695

Review 6.  Fetal gene transfer.

Authors:  Simon N Waddington; Suzanne Mk Buckley; Anna L David; Donald M Peebles; Charles H Rodeck; Charles Coutelle
Journal:  Curr Opin Mol Ther       Date:  2007-10

7.  Histogenesis and organogenesis of the gonad in human embryos.

Authors:  M Satoh
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

8.  The origin, migration and fine morphology of human primordial germ cells.

Authors:  T Fujimoto; Y Miyayama; M Fuyuta
Journal:  Anat Rec       Date:  1977-07

9.  Effects of three courses of maternally administered dexamethasone at 0.7, 0.75, and 0.8 of gestation on prenatal and postnatal growth in sheep.

Authors:  Michelle A Kutzler; Erin K Ruane; Turhan Coksaygan; Stella E Vincent; Peter W Nathanielsz
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124

10.  Transgenic mice produced by retroviral transduction of male germ line stem cells in vivo.

Authors:  Mito Kanatsu-Shinohara; Shinya Toyokuni; Takashi Shinohara
Journal:  Biol Reprod       Date:  2004-06-09       Impact factor: 4.285

View more
  11 in total

1.  Expression levels of the PiT-2 receptor explain, in part, the gestational age-dependent alterations in transduction efficiency after in utero retroviral-mediated gene transfer.

Authors:  Ferhat Ozturk; Paul J Park; Joseph Tellez; Evan Colletti; Maribeth V Eiden; Graça Almeida-Porada; Christopher D Porada
Journal:  J Gene Med       Date:  2012-03       Impact factor: 4.565

2.  Engraftment potential of adipose tissue-derived human mesenchymal stem cells after transplantation in the fetal rabbit.

Authors:  Itziar Martínez-González; Rafael Moreno; Jordi Petriz; Eduard Gratacós; Josep M Aran
Journal:  Stem Cells Dev       Date:  2012-07-31       Impact factor: 3.272

3.  Gene therapy: the promise of a permanent cure.

Authors:  Christopher D Porada; Christopher Stem; Graca Almeida-Porada
Journal:  N C Med J       Date:  2013 Nov-Dec

Review 4.  Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting).

Authors:  Akos Herzeg; Graça Almeida-Porada; R Alta Charo; Anna L David; Juan Gonzalez-Velez; Nalin Gupta; Larissa Lapteva; Billie Lianoglou; William Peranteau; Christopher Porada; Stephan J Sanders; Teresa N Sparks; David H Stitelman; Evi Struble; Charlotte J Sumner; Tippi C MacKenzie
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

5.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

6.  Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A.

Authors:  Martin Rodriguez; Christopher D Porada; Graҫa Almeida-Porada
Journal:  Curr Stem Cell Rep       Date:  2019-11-20

Review 7.  A narrative review of in utero gene therapy: advances, challenges, and future considerations.

Authors:  Nicholas K Yung; Nathan L Maassel; Sarah J Ullrich; Adele S Ricciardi; David H Stitelman
Journal:  Transl Pediatr       Date:  2021-05

Review 8.  The fetal respiratory system as target for antenatal therapy.

Authors:  J Toelen; M Carlon; F Claus; R Gijsbers; I Sandaite; K Dierickx; R Devlieger; K Devriendt; A Debeer; M Proesmans; Z Debyser; A J Deprest
Journal:  Facts Views Vis Obgyn       Date:  2011

Review 9.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

Review 10.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.